Daniel Arias
Stock Analyst at Stifel Nicolaus
(4.09)
# 1,632
Out of 4,596 analysts
501
Total ratings
47.9%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintained: Buy | $130 → $180 | $161.99 | +11.12% | 18 | Aug 3, 2026 | |
| TEM Tempus AI | Maintained: Hold | $60 → $50 | $43.87 | +13.97% | 12 | Aug 3, 2026 | |
| ILMN Illumina | Rated: Buy | $155 → $225 | $205.10 | +9.70% | 48 | Jul 31, 2026 | |
| MTD Mettler-Toledo International | Maintained: Buy | $1,400 | $1,416.30 | -1.15% | 30 | Jul 31, 2026 | |
| AVTR Avantor | Rated: Hold | $8 → $15 | $13.78 | +8.85% | 19 | Jul 30, 2026 | |
| RGEN Repligen | Maintained: Buy | $207 | $141.01 | +46.80% | 32 | Jul 29, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $600 | $574.30 | +4.48% | 32 | Jul 24, 2026 | |
| DHR Danaher | Maintained: Buy | $260 → $220 | $194.98 | +12.83% | 27 | Jul 22, 2026 | |
| MXCT MaxCyte | Maintained: Buy | $4 | $1.05 | +280.95% | 16 | Jul 22, 2026 | |
| QGEN Qiagen | Maintained: Hold | $36 | $41.40 | -13.04% | 19 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $25.36 | +10.41% | 2 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $138.37 | +22.86% | 26 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $380 | $377.31 | +0.71% | 28 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.13 | +275.59% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $6.57 | -8.68% | 24 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $62.84 | -28.39% | 23 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $50 | $72.09 | -30.64% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $10 | $8.01 | +24.84% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 | $138.60 | +4.62% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 → $100 | $112.52 | -11.13% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $25 | $47.27 | -47.11% | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.40 | +257.14% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.78 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.90 | n/a | 13 | Mar 1, 2024 |
Guardant Health
Aug 3, 2026
Maintained: Buy
Price Target: $130 → $180
Current: $161.99
Upside: +11.12%
Tempus AI
Aug 3, 2026
Maintained: Hold
Price Target: $60 → $50
Current: $43.87
Upside: +13.97%
Illumina
Jul 31, 2026
Rated: Buy
Price Target: $155 → $225
Current: $205.10
Upside: +9.70%
Mettler-Toledo International
Jul 31, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,416.30
Upside: -1.15%
Avantor
Jul 30, 2026
Rated: Hold
Price Target: $8 → $15
Current: $13.78
Upside: +8.85%
Repligen
Jul 29, 2026
Maintained: Buy
Price Target: $207
Current: $141.01
Upside: +46.80%
Thermo Fisher Scientific
Jul 24, 2026
Maintained: Buy
Price Target: $600
Current: $574.30
Upside: +4.48%
Danaher
Jul 22, 2026
Maintained: Buy
Price Target: $260 → $220
Current: $194.98
Upside: +12.83%
MaxCyte
Jul 22, 2026
Maintained: Buy
Price Target: $4
Current: $1.05
Upside: +280.95%
Qiagen
Jun 16, 2026
Maintained: Hold
Price Target: $36
Current: $41.40
Upside: -13.04%
Jun 9, 2026
Maintained: Buy
Price Target: $28
Current: $25.36
Upside: +10.41%
May 28, 2026
Maintained: Buy
Price Target: $170
Current: $138.37
Upside: +22.86%
May 18, 2026
Maintained: Hold
Price Target: $380
Current: $377.31
Upside: +0.71%
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $2.13
Upside: +275.59%
May 11, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $6.57
Upside: -8.68%
May 8, 2026
Rated: Hold
Price Target: $40 → $45
Current: $62.84
Upside: -28.39%
May 7, 2026
Maintained: Hold
Price Target: $65 → $50
Current: $72.09
Upside: -30.64%
May 7, 2026
Rated: Buy
Price Target: $8 → $10
Current: $8.01
Upside: +24.84%
May 7, 2026
Rated: Buy
Price Target: $145
Current: $138.60
Upside: +4.62%
May 6, 2026
Rated: Hold
Price Target: $110 → $100
Current: $112.52
Upside: -11.13%
Mar 2, 2026
Maintained: Buy
Price Target: $20 → $25
Current: $47.27
Upside: -47.11%
Nov 10, 2025
Maintained: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $7.78
Upside: n/a
Mar 1, 2024
Maintained: Buy
Price Target: $5
Current: $1.90
Upside: n/a